ArticleArchives of medical science : AMS2021

BST2 promotes growth and induces gefitinib resistance in oral squamous cell carcinoma via regulating the EGFR pathway.

Huang Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.